The Globe and Mail has featured several full pages of research conducted by the Population Health Research Institute in a supplement provided by Hamilton Health Sciences and McMaster University. The June 22, 2018 feature includes 12 of the studies starting from 2000 with HOPE and running until 2018 with MANAGE.
August 15, 2025
Heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients
A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce...
Read More